SCHEMBL6711933

SCHEMBL6711933

CCn1c(C(=O)Nc2ccc(Cl)cc2-c2nnn[nH]2)cc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.43
MAPT P10636 1/20 0.40
GRM4 Q14833 1/20 0.40
ROCK1 Q13464 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CCKAR P32238 1/20 0.38
PPARG P37231 1/20 0.38
KDM1A O60341 1/20 0.38
HTT P42858 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
F10 P00742 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
F2 P00734 1/20 0.38
CCR2 P41597 1/20 0.38
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710348 0.93 ALDH1A1 (0.41) PTGDR2GRM4ROCK1MEN1KMT2A
SCHEMBL6707974 0.91 CNR2 (0.42) PTGDR2MAPTGRM4ROCK1MEN1
SCHEMBL6708731 0.90 CNR2 (0.46) PTGDR2GRM4MEN1KMT2AHTT
SCHEMBL6708039 0.90 F10 (0.40) GRM4ROCK1MEN1KMT2ACCKAR
SCHEMBL6710324 0.90 ROCK1 (0.50) PTGDR2ROCK1MEN1KMT2ACCKAR
SCHEMBL6710275 0.89 HDAC3 (0.43) GRM4ROCK1MEN1KMT2ACCKAR
SCHEMBL6711541 0.89 HIF1A (0.41) PTGDR2MAPTROCK1MEN1KMT2A
SCHEMBL6708584 0.88 ROCK1 (0.38) MAPTGRM4ROCK1MEN1KMT2A
SCHEMBL6713205 0.88 GRM4 (0.52) PTGDR2GRM4ROCK1MEN1KMT2A
SCHEMBL6711776 0.86 ROCK2 (0.39) PTGDR2MAPTPPARGKDM1AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PTGDR2 2646/4885MAPT 4754/4885GRM4 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.